Perioperative Chemo Feasible for Resectable Pancreatic Cancer
Phase 2 randomized trial revealed similar overall survival for two active regimens compared with adjuvant therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.